A historic shift in Canadian drug policy has occurred, as the authorities allow the availability of psilocybin mushrooms for therapeutic treatment. Before this, these substances were severely restricted, but a increasing body of research suggests they could offer aid for emotional illnesses like depression. This change represents a major step towar